2019
Photodynamic therapy for cutaneous squamous cell carcinoma in situ: Impact of anatomic location, tumor diameter, and incubation time on effectiveness
Kibbi N, Zhang Y, Leffell DJ, Christensen SR. Photodynamic therapy for cutaneous squamous cell carcinoma in situ: Impact of anatomic location, tumor diameter, and incubation time on effectiveness. Journal Of The American Academy Of Dermatology 2019, 82: 1124-1130. PMID: 31712171, DOI: 10.1016/j.jaad.2019.10.079.Peer-Reviewed Original ResearchMeSH KeywordsAgedAged, 80 and overAminolevulinic AcidAnalysis of VarianceBiopsy, NeedleCarcinoma in SituCarcinoma, Squamous CellCohort StudiesDisease-Free SurvivalFemaleHumansImmunohistochemistryLogistic ModelsMaleMiddle AgedMultivariate AnalysisNeoplasm InvasivenessNeoplasm StagingPhotochemotherapyPrognosisRetrospective StudiesSkin NeoplasmsSurvival AnalysisTreatment OutcomeTumor BurdenConceptsCutaneous squamous cell carcinomaALA incubation timeSquamous cell carcinomaTumor diameterALA-PDTSubsequent recurrenceCell carcinomaAnatomic locationInitial complete response ratePhotodynamic therapyCases of SCCISMultivariate analysis factorsComplete response rateMedical record reviewEffectiveness of PDTPatient demographicsClinical responseMedian timeRetrospective reviewRecord reviewRetrospective studyTreatment detailsSingle institutionEffective treatmentResponse rate
2018
Recent advances in field cancerization and management of multiple cutaneous squamous cell carcinomas
Christensen SR. Recent advances in field cancerization and management of multiple cutaneous squamous cell carcinomas. F1000Research 2018, 7: f1000 faculty rev-690. PMID: 29904586, PMCID: PMC5989149, DOI: 10.12688/f1000research.12837.1.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsSquamous cell carcinomaMultiple squamous cell carcinomasCutaneous squamous cell carcinomaField cancerizationPrecursor lesionsCell carcinomaMultiple cutaneous squamous cell carcinomasIncident squamous cell carcinomaSubsequent squamous cell carcinomaField-directed therapySevere actinic damageTopical ingenol mebutateMultiple primary cancersManagement of patientsSubsequent cancer developmentSystemic acitretinTopical imiquimodPrimary cancerCommon cancerMultiple tumorsIngenol mebutateSCC developmentActinic damageField therapyPatients